Glycopedia
@glycopedia
LectomeXplore, an update of UniLectin.eu for the discovery of carbohydrate-binding proteins based on a new lectin classification not here anymore GlycomicsExpasy Glycopedia Please give a feedback ! doi.org/10.1093/nar/gk…
"Should its efforts succeed, the Caribbean island could become an important supplier to neighboring countries that might otherwise struggle to access vaccine supply as wealthy Western nations rush to secure doses..." Thanks Sarah Marsh for the nice article and comments!
Otto e Mezzo AIFA Luca Telese Corriere della Sera La7 Menzionare i due vaccini-candidati Cubani in clinical trial, pubblici, no-profit, e totalmente unici nel suo genere, sarebbe giornalismo tantomeno "giusto"... chiedete in giro in Italia se si preferisce un vaccino Pfizer o uno cubano...eh già, esistono vaccini pubblici...a Cuba
A very clear and elegant analysis from our Director Vicente Vérez Bencomo Instituto Finlay de Vacunas, explaining Mesa Redonda the advances of the two Cuban vaccine-candidates. In attached a very important slide on vaccine-safety and development, and the video link: youtu.be/blfZHzO-6jY
Congratulations to Dania Martinez for super work on a new propeller lectin (my favorite ones) PhD4GlycoDrug Glyco@Alps @CermavDirection Université Grenoble Alpes
Starch follows phyllotaxic rules... and it is beautiful. Collab. between Mr Glycopedia @CermavDirection and European Synchrotron published in Scientific Reports nature.com/articles/s4159…
Project Syndicate Mariana Mazzucato Els Torreele I am sure one day you will also describe the Cuban Biotechnology, their therapeutic approaches, drugs and their SARS-CoV-2 vaccine-candidates...since 1960 with a brutal embargo, but with top level biopharmaceutics, Public, no profit, distributed around the World to poor Countries
Congratulations to new Dr François Bulteau for successful PhD exam . Excellent discussion with prof Richard Daniellou and other members of thé comittee
La Asamblea Nacional Cuba reconoce a la ciencia #cubana por su aporte en la batalla contra #COVID19. El Instituto Finlay de Vacunas también estuvo presentes con sus #soberanas. Emocionante!!. Seguimos con nuestro compromiso. #CubaSalva.
Kai Kupferschmidt Remember also the example of the Cuban Public Biotech, with four SARS-CoV-2 vaccine-candidates in clinical trial...Sub-unit, low cost, no profit and fully Public...These ones will be the real People's vaccines...(COVAX knows about it...)
